Hospital-acquired infective endocarditis during Covid-19 pandemic.
Coronavirus
Cross-infection
Echocardiography
Endocarditis
Enterococcus faecalis
Transesophageal
Journal
Infection prevention in practice
ISSN: 2590-0889
Titre abrégé: Infect Prev Pract
Pays: England
ID NLM: 101777928
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
03
06
2020
accepted:
23
07
2020
entrez:
28
7
2021
pubmed:
29
7
2021
medline:
29
7
2021
Statut:
ppublish
Résumé
The COVID pandemic has had a major impact on healthcare in hospitals, including the diagnosis and treatment of infections. Hospital-acquired infective endocarditis (HAIE) is a severe complication of medical procedures that has shown a progressive increase in recent years. To determine whether the incidence of HAIE during the first two months of the epidemic (March-April 2020) was higher than previously observed and to describe the clinical characteristics of these cases. The probability of the studied event (HAIE) during the study period was calculated by Poisson distribution. Four cases of HAIE were diagnosed in our institution during the study period. The incidence of HAIE during the study period was 2/patient-month and 0.3/patient-month during the same calender months in the previous 5 years (p=0.033). Two cases presented during admission for COVID-19 with pulmonary involvement treated with methylprednisolone and tocilizumab. The other two cases were admitted to the hospital during the epidemic. All cases underwent central venous and urinary catheterization during admission. The etiology of HAIE was The incidence of HAIE during COVID-19 pandemic in our institution was higher than usual. In order to reduce the risk of this serious infection, optimal catheter care and early treatment of every local infection should be prioritized during coronavirus outbreaks.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID pandemic has had a major impact on healthcare in hospitals, including the diagnosis and treatment of infections. Hospital-acquired infective endocarditis (HAIE) is a severe complication of medical procedures that has shown a progressive increase in recent years.
OBJECTIVES
OBJECTIVE
To determine whether the incidence of HAIE during the first two months of the epidemic (March-April 2020) was higher than previously observed and to describe the clinical characteristics of these cases. The probability of the studied event (HAIE) during the study period was calculated by Poisson distribution.
RESULTS
RESULTS
Four cases of HAIE were diagnosed in our institution during the study period. The incidence of HAIE during the study period was 2/patient-month and 0.3/patient-month during the same calender months in the previous 5 years (p=0.033). Two cases presented during admission for COVID-19 with pulmonary involvement treated with methylprednisolone and tocilizumab. The other two cases were admitted to the hospital during the epidemic. All cases underwent central venous and urinary catheterization during admission. The etiology of HAIE was
CONCLUSIONS
CONCLUSIONS
The incidence of HAIE during COVID-19 pandemic in our institution was higher than usual. In order to reduce the risk of this serious infection, optimal catheter care and early treatment of every local infection should be prioritized during coronavirus outbreaks.
Identifiants
pubmed: 34316565
doi: 10.1016/j.infpip.2020.100080
pii: S2590-0889(20)30044-5
pmc: PMC7391975
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100080Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
None declared.
Références
Clin Infect Dis. 2008 Nov 15;47(10):1287-97
pubmed: 18834314
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
J Infect. 2011 Apr;62(4):317-8
pubmed: 21300105
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Kardiol Pol. 2020 Apr 24;78(4):357-363
pubmed: 32241097
Emerg Infect Dis. 2010 Sep;16(9):1493-5
pubmed: 20735945
Chest. 2020 Sep;158(3):1268-1281
pubmed: 32361152
J Infect. 2004 Jan;48(1):23-31
pubmed: 14667789
Chest. 2005 Aug;128(2):772-9
pubmed: 16100166
Clin Microbiol Infect. 2017 Jun;23(6):416-417
pubmed: 27986520
Cochrane Database Syst Rev. 2020 Apr 21;4:CD013582
pubmed: 32315451
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1124-1125
pubmed: 32317036
Clin Microbiol Infect. 2010 Nov;16(11):1683-90
pubmed: 19732086
J Clin Virol. 2020 Jun;127:104364
pubmed: 32311650
Int J Tuberc Lung Dis. 2020 May 1;24(5):547-548
pubmed: 32398214
Ann Rheum Dis. 2019 Apr;78(4):456-464
pubmed: 30679153
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Mayo Clin Proc. 2007 Oct;82(10):1165-9
pubmed: 17908522
J Clin Virol. 2020 May;126:104338
pubmed: 32278299
PLoS One. 2013 Dec 09;8(12):e82665
pubmed: 24349331
Swiss Med Wkly. 2020 Apr 09;150:w20241
pubmed: 32271935
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Allergy. 2020 Jul;75(7):1699-1709
pubmed: 32196678